Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome.

Long-term repeated use of RTX may be effective and safe in pediatric NS patients. Furthermore, the redosing of RTX could be chosen by considering predictive factors for relapse-free and B-cell depletion periods. A higher resolution version of the Graphical abstract is available as Supplementary information.